These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9786484)

  • 1. Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection.
    Shah PM
    J Antimicrob Chemother; 1998 Sep; 42(3):399. PubMed ID: 9786484
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
    Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
    J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of quinolones against Y. pestis].
    Kalininskiĭ VB; Vasil'ev NT; Iudin SM
    Antibiot Khimioter; 1989 Jul; 34(7):521-3. PubMed ID: 2818084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
    Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV
    Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonic plague].
    Hovette P; Burgel PR; Camara P; Sane M; Auregan G; Klotz F
    Rev Pneumol Clin; 1998 Dec; 54(6):373-6. PubMed ID: 10100351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection].
    Ryzhkova VV; Pavlovich NV; Makarovskaia LN; Zurabian VA; Bespalova IA; Goncharov EK; Bugaeva OK; Malsova NN
    Antibiot Khimioter; 1996 Feb; 41(2):35-9. PubMed ID: 8929117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonic plague.
    Krishna G; Chitkara RK
    Semin Respir Infect; 2003 Sep; 18(3):159-67. PubMed ID: 14505278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plague.
    Cobbs CG; Chansolme DH
    Dermatol Clin; 2004 Jul; 22(3):303-12, vi. PubMed ID: 15207311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plague].
    Yanagihara I; Honda T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):119-22. PubMed ID: 10088352
    [No Abstract]   [Full Text] [Related]  

  • 13. Yersinia pestis: still a plague in the 21st century.
    Josko D
    Clin Lab Sci; 2004; 17(1):25-9. PubMed ID: 15011977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plague into the 21st century.
    Butler T
    Clin Infect Dis; 2009 Sep; 49(5):736-42. PubMed ID: 19606935
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful Treatment of Human Plague with Oral Ciprofloxacin.
    Apangu T; Griffith K; Abaru J; Candini G; Apio H; Okoth F; Okello R; Kaggwa J; Acayo S; Ezama G; Yockey B; Sexton C; Schriefer M; Mbidde EK; Mead P
    Emerg Infect Dis; 2017 Mar; 23(3):553-5. PubMed ID: 28125398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene.
    Kuberski T; Robinson L; Schurgin A
    Clin Infect Dis; 2003 Feb; 36(4):521-3. PubMed ID: 12567312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments.
    Vagima Y; Gur D; Erez N; Achdout H; Aftalion M; Levy Y; Zauberman A; Tidhar A; Gutman H; Lazar S; Israely T; Paran N; Melamed S; Brosh-Nissimov T; Chitlaru T; Sagi I; Mamroud E
    Sci Rep; 2020 Nov; 10(1):19116. PubMed ID: 33154422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yersinia pestis as a dangerous biological weapon].
    Grygorczuk S; Hermanowska-Szpakowicz T
    Med Pr; 2002; 53(4):343-8. PubMed ID: 12474416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.
    Lindler LE; Fan W; Jahan N
    J Clin Microbiol; 2001 Oct; 39(10):3649-55. PubMed ID: 11574586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.